Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lisa C. Gold"'
Autor:
Noriko Itoh, Yuichiro Itoh, Cassandra E. Meyer, Timothy Takazo Suen, Diego Cortez-Delgado, Michelle Rivera Lomeli, Sophia Wendin, Sri Sanjana Somepalli, Lisa C. Golden, Allan MacKenzie-Graham, Rhonda R. Voskuhl
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Menopause is associated with cognitive deficits and brain atrophy, but the brain region and cell-specific mechanisms are not fully understood. Here, we identify a sex hormone by age interaction whereby loss of ovarian hormones in female mice
Externí odkaz:
https://doaj.org/article/3da7fc5c3dd84fa0a4e905cc39ec2b00
Autor:
Robert Williams, Ravi Koopot, Karen Lewis, Mark F. Rudinsky, Stephen D. Barbour, Lisa C. Gold, Lourdes M. Guerrero-Tiro
Publikováno v:
The Pediatric infectious disease journal. 15(4)
Autor:
Taeksun Song, Myungsun Lee, Han-Seung Jeon, Yumi Park, Lori E. Dodd, Véronique Dartois, Dean Follman, Jing Wang, Ying Cai, Lisa C. Goldfeder, Kenneth N. Olivier, Yingda Xie, Laura E. Via, Sang Nae Cho, Clifton E. Barry III, Ray Y. Chen
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1627-1633 (2015)
Long-term linezolid use is limited by mitochondrial toxicity-associated adverse events (AEs). Within a prospective, randomized controlled trial of linezolid to treat chronic extensively drug-resistant tuberculosis, we serially monitored the translati
Externí odkaz:
https://doaj.org/article/7beaa75555b04827aa0e2b13b0e0cec4
Autor:
Ray Y. Chen, Laura E. Via, Lori E. Dodd, Gerhard Walzl, Stephanus T. Malherbe, André G. Loxton, Rodney Dawson, Robert J. Wilkinson, Friedrich Thienemann, Michele Tameris, Mark Hatherill, Andreas H. Diacon, Xin Liu, Jin Xing, Xiaowei Jin, Zhenya Ma, Shouguo Pan, Guolong Zhang, Qian Gao, Qi Jiang, Hong Zhu, Lili Liang, Hongfei Duan, Taeksun Song, David Alland, Michael Tartakovsky, Alex Rosenthal, Christopher Whalen, Michael Duvenhage, Ying Cai, Lisa C. Goldfeder, Kriti Arora, Bronwyn Smith, Jill Winter, Clifton E. Barry III, Predict TB Study Group
Publikováno v:
Gates Open Research, Vol 1 (2017)
Background: By the early 1980s, tuberculosis treatment was shortened from 24 to 6 months, maintaining relapse rates of 1-2%. Subsequent trials attempting shorter durations have failed, with 4-month arms consistently having relapse rates of 15-20%. On
Externí odkaz:
https://doaj.org/article/2e9744f070dd42cc8f0373c77478494c